Skip to main content
. 2020 Nov 11;90(2):250–252. doi: 10.1038/s41390-020-01259-8

Table 1.

Sample of observational pediatric-specific registries and studies on COVID-19.

Study Type Scopea Inclusion criteria Capability for data sharing and reuse
Australian Neonatal COVID-19 Study Registry Reporting by designated clinicians in Australia Mother/infant dyad hospitalized in perinatal period with suspected or laboratory-confirmed COVID-19 Specified procedures for data sharing and reuse
BPSU Study: Neonatal complications of COVID-19 (British Paediatric Surveillance Unit Study) Surveillance study Hospitals in the United Kingdom and Northern Ireland Neonate (aged <29 days) hospitalized with confirmed COVID-19 or born to mother with confirmed infection Limited access to data via application
COVID-19 and Childhood Cancer Registry Registry Healthcare providers globally Patients aged <19 years with malignancy or prior hematopoietic stem cell transplant Not possible at this time
COVID-19 Data: North American Pediatric ICUs Dashboard Hospitals in North America Patients with confirmed COVID-19 and admitted to pediatric ICU Not specified
COVID-19 Pediatric Rheumatology Database Registry Sites globally Patients aged <19 years with any type of pediatric rheumatic disease Limited access to data via application
COVID-19—service evaluation and audit Surveillance study Hospitals in England Patients aged 29 days to <18 years hospitalized with confirmed COVID-19 Not specified
EPICENTRE Registry Hospitals globally with an active pediatric or neonatal ICU Neonate (up to 30 days) or child (aged 30 days to <18 years) hospitalized with confirmed COVID-19 and requiring critical care or born to mother with confirmed infection Limited access to data via application
International COVID-19 PICU Collaborative Research collaborative Set of pediatric hospitals in North America Patients aged <21 years with confirmed COVID-19 and admitted to pediatric ICU Not specified
National Registry for Surveillance and Epidemiology of Perinatal COVID-19 Infections Registry Hospitals in the US with newborn delivery services Mother/infant dyad where mother has confirmed COVID-19 in the perinatal period Not possible at this time
Overcoming COVID-19 Surveillance study Pre-specified set of hospitals in the US Patients aged <26 years hospitalized with confirmed COVID-19 Not possible at this time
PAN-COVID (Pregnancy And Neonatal outcomes for women with COVID-19) Registry Hospitals globally where clinician has registered to contribute data Neonate of mother with suspected or confirmed COVID-19 Not specified
Pediatric COVID-19 Convalescent Plasma Use Registry Study Registry Hospitals in the US Patients aged <18 years of age who received COVID-19 convalescent plasma transfusion Not specified
Pediatric COVID-19 US Registry Registry Sites in the US Patients aged <21 years with confirmed COVID-19 Limited access to data via application

PERN COVID-19 study

(Pediatric Emergency Research Network COVID-19 study)

Prospective observational study Pre-specified set of 50 emergency departments across 11 countries Patients aged <18 years tested for COVID-19 in the emergency department Not possible at this time
Pediatric Intensive Care Audit Network (PICANet) Surveillance Pediatric ICUs within the UK Patients aged <18 years with suspected or confirmed COVID-19 admitted to pediatric ICU Limited access to data via application

The PAWS-COVID-19 Registry

(Pediatric AirWays ComplicationS COVID-19 Registry)

Registry Hospitals globally Patients aged <19 years undergoing anesthesia during the pandemic, including cohorts with confirmed and suspected COVID-19 Not specified
WHO Global COVID-19 Clinical Platform: multisystem inflammatory syndrome (MIS) in children and adolescents Registry Hospitals globally Patients aged <20 years suspected to have multisystem inflammatory  syndrome temporally related to COVID-19 Not specified

COVID-19 coronavirus disease 2019, ICU intensive care unit.

aReflects eligibility or participation and data contribution based on available reports as of  November 9, 2020.